New agents for Gram-positive bacteria

被引：63

作者：

Bhavnani, SM ^{[1
]}

Ballow, CH

机构：

[1] Kaleida Hlth Millard Fillmore Hosp, Clin Pharmacokinet Lab, Buffalo, NY 14209 USA

[2] SUNY Buffalo, Sch Pharm, Buffalo, NY 14209 USA

来源：

CURRENT OPINION IN MICROBIOLOGY | 2000年 / 3卷 / 05期

关键词：

D O I：

10.1016/S1369-5274(00)00134-X

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Infections caused by multiple-resistant Gram-positive organisms continue to occur at an alarming rate worldwide. Two new and unique antimicrobial agents targeted specifically against such organisms, quinupristin/dalfopristin and linezolid, have been approved for use in the USA in the past year and will play an important role in the treatment of life-threatening infections. In addition, several new fluoroquinolones have been approved recently or will be available in the near future to aid in the treatment of infections caused by resistant strains of Streptococcus pneumoniae.

引用

页码：528 / 534

页数：7

共 77 条

[51] Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin)
McNeil, SA
Clark, NM
Chandrasekar, PH
Kauffman, CA
[J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (02) : 403 - 404
[52] The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium
Moellering, RC
Linden, PK
Reinhardt, J
Blumberg, EA
Bompart, F
Talbot, GH
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (02) : 251 - 261
[53] MOLINARI M, 2000, CLIN MICROBIOL INFEC, V6, P64
[54] MOLINARI M, 2000, CLIN MICROBIOL INFEC, V6, P136
[55] MOLINARI M, 2000, CLIN MICROBIOL LETT, V6, P137
[56] Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin
Nichols, RL
Graham, DR
Barriere, SL
Rodgers, A
Wilson, SE
Zervos, M
Dunn, DL
Kreter, B
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (02) : 263 - 273
[57] Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin
Noskin, GA
Siddiqui, F
Stosor, V
Kruzynski, J
Peterson, LR
[J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (03) : 689 - 690
[58] Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against Gram-positive and -negative organisms
Pankuch, GA
Jacobs, MR
Appelbaum, PC
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 3028 - 3031
[59] Gatifloxacin
Perry, CM
Balfour, JAB
Lamb, HM
[J]. DRUGS, 1999, 58 (04) : 683 - 696
[60] PETITPRETZ P, 1999, CLIN MICROBIOL INFEC, V5, P140

← 1 2 3 4 5 6 7 8 →